Retatrutide has not yet been approved by the MHRA and is not currently available on the NHS or privately in the UK
In addition, roughly a quarter of patients on the highest dose stopped taking the drug due to side effects, according to CNBC, complicating the premise that the pill will be easier to take and more effective than its injectable counterpart
Thus, GLP-1 was rapidly identified as a potential new treatment for diabetes and metabolic syndrome
Easy to absorb, a more gentle form, even for a sensitive stomach
How the Treatment Works Initial Consultation: Our healthcare professionals at Unique Physique will conduct a thorough assessment of your health, medical history, and weight loss goals to determine if one of our treatment options is right for you
doi: 10.3390/antiox11040745 13 AgarwalASenguptaPDurairajanayagamD